cycloheximide has been researched along with Primary Peritonitis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leduc, D; Pretolani, M; Vargaftig, BB; Zuany-Amorim, C | 1 |
| Coles, GA; Jörres, A; Topley, N; Williams, JD; Witowski, J | 1 |
| Hirota, S; Nagaoka, I | 1 |
3 other study(ies) available for cycloheximide and Primary Peritonitis
| Article | Year |
|---|---|
Characterization and pharmacological modulation of antigen-induced peritonitis in actively sensitized mice.
Topics: Animals; Benzeneacetamides; Cetirizine; Cycloheximide; Dexamethasone; Eosinophils; Histamine Release; Hydroxamic Acids; Indomethacin; Kinetics; Leukocyte Count; Leukotriene B4; Leukotriene C4; Lipoxygenase Inhibitors; Male; Mice; Mice, Inbred BALB C; Ovalbumin; Peritoneal Cavity; Peritonitis; Platelet Activating Factor; T-Lymphocytes; Tacrolimus; Terfenadine; Thiazoles; Zymosan | 1993 |
Superinduction of IL-6 synthesis in human peritoneal mesothelial cells is related to the induction and stabilization of IL-6 mRNA.
Topics: Cell Division; Cells, Cultured; Culture Media, Conditioned; Cycloheximide; Dactinomycin; Dialysis Solutions; Dose-Response Relationship, Drug; Electrophoresis, Agar Gel; Epithelial Cells; Epithelium; Gene Expression Regulation; Humans; Interleukin-1; Interleukin-6; Macrophages, Peritoneal; Models, Biological; Peritoneal Cavity; Peritonitis; Polymerase Chain Reaction; Receptors, Interleukin-1; RNA, Messenger; Time Factors | 1996 |
Increased expression of matrix metalloproteinase-9 in neutrophils in glycogen-induced peritoneal inflammation of guinea pigs.
Topics: Animals; Cycloheximide; Dactinomycin; Gene Expression; Glycogen; Guinea Pigs; Lipopolysaccharides; Male; Matrix Metalloproteinase 9; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Nucleic Acid Synthesis Inhibitors; Peritonitis; Protein Synthesis Inhibitors; RNA, Messenger; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2000 |